Drug Research
Takeda announces availability of type 2 diabetes drugs in...
Takeda Pharmaceutical Company has announced the availability of NESINA (alogliptin) and fixed-dose combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) by prescription...
Drug Research
Amedra re-launches Adrenaclick to treat anaphylaxis
Amedra Pharmaceuticals has re-launched a single-dose epinephrine auto-injector Adrenaclick for people with increased risk of anaphylaxis in both 0.15mg and 0.30mg strengths. ...
Drug Research
Eisai to market and distribute Belviq weight management therapy...
Eisai has announced the availability of Belviq (lorcaserin HCl) CIV tablets in the US, which is designed for chronic weight management in adults who are...
Drug Research
Johnson & Johnson opens California Innovation Center
Johnson & Johnson (J&J) Innovation has opened the new California Innovation Center to build early stage collaborations with emerging companies in science and technology and...
Drug Research
Second Genome signs microbiome drug discovery deal with Janssen
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the...
Drug Research
USPTO issues notice of allowance for GW Pharmaceuticals Sativex...
The USPTO has issued a notice of allowance for GW Pharmaceuticals' patent application regarding Sativex formulation spray device. The patent...
Drug Research
Nuvo Research announces launch of Pliaglis in Europe
Specialty pharmaceutical company Nuvo Research has announced the launch of Pliaglis (lidocaine and tetracaine) cream 7%/7% by Galderma in Europe. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.